Division of Cancer Medicine, Department of Oncology, Gastroenterologic Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa 920-8641, Japan.
Oncol Rep. 2010 Dec;24(6):1433-41. doi: 10.3892/or_00001003.
The immunological response in the regional lymph nodes (LN) of gastric cancer patients who had metastasis was studied by investigating both the degree of metastasis and the maturation status of dendritic cells (DCs). A total of 732 LNs was obtained from 29 gastric cancer patients, including 25 patients whose LNs were pathological metastasis-negative and 4 patients with metastasis-positive LNs. Micrometastasis (MM) in the LNs was analyzed by immunohistochemical staining of cytokeratin (CK) (IHC-MM) and by amplifying CEA and CK19 mRNA by quantitative real-time RT-PCR (PCR-MM). Distribution and density of mature DCs were evaluated in 119 LNs from pathological metastasis-positive cases by examining CD83 expression immunohistochemically. Then, following the examination of PCR-MM, immunological responses were analyzed by amplifying CD83, CD86, CD1a and IFNγ mRNA by quantitative real-time RT-PCR in 613 LNs from 25 pathological metastasis-negative cases. Among 119 LNs from 4 patients with LN metastasis, 20 LNs had histological metastasis and 6 histological metastasis-negative LNs had IHC-MM. The distribution and density of mature DCs were identical in the LNs regardless of metastasis status. Among 613 LNs from 25 patients without histological LN metastasis, 15 LNs (2.45%) from 6 cases (24%) were PCR-MM positive. The expression levels of CD83 and CD86 mRNA were significantly higher in the 15 PCR-MM-positive LNs than in the 598 PCR-MM-negative LNs. The expression levels of CD83 and CD86 mRNA in 136 PCR-MM-negative LNs from 6 PCR-MM-positive cases were also higher than those in 462 LNs from 19 PCR-MM-negative cases. In gastric cancer patients, activation of the immune response by maturation of DCs is wide-spread in regional lymph nodes at a stage before metastasis is detected histologically, including detection by IHC-MM.
本研究通过检测胃癌患者区域淋巴结(LN)中的转移程度和树突状细胞(DC)的成熟状态,来研究其免疫反应。共从 29 例胃癌患者中获得了 732 个 LN,其中 25 例患者的 LN 病理检查无转移,4 例患者的 LN 有转移。通过免疫组化染色细胞角蛋白(CK)(IHC-MM)和定量实时 RT-PCR 扩增癌胚抗原(CEA)和 CK19mRNA(PCR-MM)分析 LN 中的微转移(MM)。通过免疫组化检查 CD83 表达,对 4 例 LN 转移阳性病例的 119 个 LN 中的成熟 DC 的分布和密度进行评估。然后,在对 25 例病理检查无转移的患者的 613 个 LN 进行 PCR-MM 检查后,通过定量实时 RT-PCR 扩增 CD83、CD86、CD1a 和 IFNγmRNA 来分析免疫反应。在 4 例 LN 转移患者的 119 个 LN 中,20 个 LN 有组织学转移,6 个组织学转移阴性的 LN 有 IHC-MM。无论转移状态如何,LN 中成熟 DC 的分布和密度均相同。在 25 例无组织学 LN 转移的患者的 613 个 LN 中,6 例(24%)患者的 15 个 LN(2.45%)PCR-MM 阳性。15 个 PCR-MM 阳性 LN 中 CD83 和 CD86mRNA 的表达水平明显高于 598 个 PCR-MM 阴性 LN。6 例 PCR-MM 阳性患者的 136 个 PCR-MM 阴性 LN 中的 CD83 和 CD86mRNA 的表达水平也高于 19 例 PCR-MM 阴性患者的 462 个 LN。在胃癌患者中,在组织学上检测到转移之前,DC 的成熟就已经在区域淋巴结中广泛激活了免疫反应,包括通过 IHC-MM 检测到的反应。